These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7872178)

  • 21. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.
    Fogel RI; Herre JM; Kopelman HA; Kowey PR; Trohman RG; Fineberg N; Prystowsky EN
    Am Heart J; 2000 Apr; 139(4):690-5. PubMed ID: 10740153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients.
    Belhassen B; Shapira I; Keren G; Laniado S
    Eur Heart J; 1985 Mar; 6(3):266-75. PubMed ID: 4029184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of Sustained Ventricular Arrhythmias With Amiodarone: Prediction of Efficacy With Serial Electrophysiologic Studies.
    Nasir N; Swarna US; Boahene KA; Doyle TK; Pacifico A
    J Cardiovasc Pharmacol Ther; 1996 Apr; 1(2):123-132. PubMed ID: 10684409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of efficacy of amiodarone by electrophysiologic studies in patients with sustained ventricular tachycardia].
    Yamaguchi I; Maeda H; Kurihara T; Endo M; Kuga K; Sugishita Y
    Jpn Circ J; 1992; 56 Suppl 5():1465-9. PubMed ID: 1291744
    [No Abstract]   [Full Text] [Related]  

  • 27. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
    Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
    Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
    Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
    Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing.
    Krafchek J; Lin HT; Beckman KJ; Nielsen AP; Magro SA; Hargis J; Wyndham CR
    Pacing Clin Electrophysiol; 1988 Apr; 11(4):434-44. PubMed ID: 2453040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J; Haines DE; Lerman BB; DiMarco JP
    Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy.
    Kadish AH; Buxton AE; Waxman HL; Flores B; Josephson ME; Marchlinski FE
    J Am Coll Cardiol; 1987 Jul; 10(1):90-6. PubMed ID: 3598000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
    Zehender M; Faber T; Furtwängler A; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1992 Dec; 81(12):704-9. PubMed ID: 1492440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW; Finerman WB; Peter T; Mandel WJ
    Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
    Fananapazir L; Epstein SE
    Am J Cardiol; 1991 Jan; 67(2):175-82. PubMed ID: 1987719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
    Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
    Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.